muscle pain after tirzepatide Does Cause Loss? Clinical Evidence and Prevention Injecting Tirzepatide Into Muscle: Risks

3 in the non-GLP-1 RA group

Statistical analysis The proportional reporting ratio (PRR) is used to evaluate the generation of signals in the surveillance database, which is calculated as follows (Evans et al., 2001): A PRR of 1 indicates that GLP-1RA-associated neoplasms were reported as frequently as comparator-associated neoplasms

For the growing population of patients with the co-morbid conditions of hypertension, diabetes, and obesity, GLP-1 RAs represent an opportunity to simultaneously treat multiple risk factors with one agent

10.1071/rd22033 58 SjaardaL

If youre curious about whether a dual-action medication could be suitable for your health goals, we invite you to complete our [free assessment quiz]

10.3390/biom10111489 125 UzungilV.TranH.AitkenC.WilsonC.OpazoC